Category: Ecosystem News

Cetya Therapeutics Announces Issuance of New Patents Covering its HDAC Inhibitor CT-102

By: Colorado BioScience Association   Date: 06/12/2020

Cetya Therapeutics, Inc. today announced issuance of US Patent No. 10,676,504 and Australian Patent No. 2016229324 covering CT-102, Cetya’s proprietary HDAC inhibitor. CT-102 has demonstrated excellen...

Learn More

Flagship Biosciences Names Aymii Couzelis as Chief Information Officer

By: Colorado BioScience Association   Date: 06/03/2020

Flagship Biosciences, providers of expert tissue data insights, today announced that Aymii Couzelis has been named to its executive team as Chief Information Officer. Aymii brings over 20 years of exp...

Learn More

ARCA Biopharma Announces AB201 Development Program For Treatment of COVID-19 Associated Coagulopathy

By: Colorado BioScience Association   Date: 05/28/2020

ARCA biopharma, Inc. (Nasdaq: ABIO) today announced a new development program to evaluate AB201 (rNAPc2), a potent, selective inhibitor of tissue factor (TF), as a potential treatment for COVID-19 ass...

Learn More

$7.3 Million Advanced Industries Awards Fuel 27 Colorado Start-ups

By: Colorado BioScience Association   Date: 05/26/2020

Colorado Office of Economic Development and International Trade (OEDIT)’s Advanced Industries Accelerator Grant Program realeased a list of 27 Colorado start-ups approved for funding. A total of...

Learn More

ArcherDX Receives Breakthrough Device Designation to Detect NTRK Gene Fusions

By: Colorado BioScience Association   Date: 05/20/2020

ArcherDX, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its next-generation sequencing (NGS) device under development as a compa...

Learn More

Accure Receives CE Mark Approval for First-Ever 1726nm Laser Platform to treat Acne

By: Colorado BioScience Association   Date: 05/16/2020

Groundbreaking platform combines novel laser wavelength with fully integrated tissue temperature monitoring and control systems to deliver a paradigm-shifting non-systemic solution for acne sufferers....

Learn More

Bayer and ArcherDX Announce Global Collaboration to Develop Next-Generation Sequencing (NGS)-based Companion Diagnostic (CDx) for VITRAKVI® (larotrectinib)

By: Colorado BioScience Association   Date: 05/14/2020

Collaboration will focus on development of a companion diagnostic (CDx) for Vitrakvi®, the first-in-class tyrosine kinase (TRK) inhibitor approved in the U.S. and Europe for adult pediatric patients w...

Learn More

Tolmar Pharmaceuticals Receives FDA Approval

By: Colorado BioScience Association   Date: 05/05/2020

FDA Approves FENSOLVI® (leuprolide acetate) for Injectable Suspension for Pediatric Patients with Central Precocious Puberty. Fensolvi is the only six-month, subcutaneously administered leuprolide ace...

Learn More

Global Plasma Leaders Collaborate to Accelerate Development of Potential Covid-19 Hyperimmune Therapy

By: Colorado BioScience Association   Date: 04/09/2020

Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the global fight against COVID-19. Learn more in the press release.

Learn More

MBio to Seek FDA Approval for LightDeck® Platform

By: Colorado BioScience Association   Date: 04/07/2020

MBio Diagnostics today announced an expanded scope contract with the US Defense Advanced Research Projects Agency (DARPA), where DARPA will apply additional resources and funds to accelerate progress...

Learn More